Voloridge Investment Management
AVXL icon

Voloridge Investment Management’s Anavex Life Sciences AVXL Stock Holding History

Voloridge Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-150,710
Closed -$2.71M – 1575
2021
Q3 		$2.71M Sell
150,710
-33,829
-18% -$673K 0.02% 935
2021
Q2 		$4.22M Buy
+184,539
New +$2.73M 0.03% 706
2021
Q1 		– Sell
-41,951
Closed -$227K – 1383
2020
Q4 		$227K Buy
+41,951
New +$221K ﹤0.01% 1253

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voloridge Investment Management's AVXL Position: Q4 2021 in Review

Voloridge Investment Management sold out of Anavex Life Sciences (AVXL) in Q4 2021, closing a stake of 150,710 shares — an estimated $2.71M sold.

Voloridge Investment Management first reported a position in AVXL in Q4 2020 and held it in 3 quarters. The position peaked at $4.22M in Q2 2021. 149 funds tracked by Wall St. Rank hold AVXL as of Q4 2021.

  • Voloridge Investment Management reported no remaining Anavex Life Sciences position as of Q4 2021 after selling out during the quarter.
  • Voloridge Investment Management sold 150,710 Anavex Life Sciences shares in Q4 2021, an estimated $2.71M.
  • Voloridge Investment Management first reported a position in Anavex Life Sciences in Q4 2020 and held it in 3 quarters.
  • Voloridge Investment Management's Anavex Life Sciences position peaked at $4.22M in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2021.

Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.